A radiochemical method for selective measurement of postheparin lipase activities was adapted to analyze lipoprotein lipase and hepatic lipase in preheparin plasma. The assay sensitivity was increased about fourfold by doubling both the volume of plasma used and the volume of lipolytic products taken for liquid scintillation counting, and was further improved by increasing the incubation period by 50% to 90 mm. Rabbit antiserum to human hepatic lipase was unsuitable for the selective measurement of lipoprotein lipase because of apparent endogenous lipolytic activity. Preheparin hepatic lipase, however, was sensitive to inactivation by sodium dodecyl sulfate (SDS), the inhibition being greatest (>90%) for plasma incubated with an equal volume of 40 mmoVL SDS. Intra-and interassay CVs for the two enzymes were 12.5-14.6%
A radiochemical method for selective measurement of postheparin lipase activities was adapted to analyze lipoprotein lipase and hepatic lipase in preheparin plasma. The assay sensitivity was increased about fourfold by doubling both the volume of plasma used and the volume of lipolytic products taken for liquid scintillation counting, and was further improved by increasing the incubation period by 50% to 90 mm. Rabbit antiserum to human hepatic lipase was unsuitable for the selective measurement of lipoprotein lipase because of apparent endogenous lipolytic activity. Preheparin hepatic lipase, however, was sensitive to inactivation by sodium dodecyl sulfate (SDS), the inhibition being greatest (>90%) for plasma incubated with an equal volume of 40 mmoVL SDS. Intra-and interassay CVs for the two enzymes were 12.5-14.6% and 17.4-19.7%, respectively. In a crosssectional study of 84 healthy subjects, pre-and postheparm hepatic lipase activities were higher in men than women, were correlated with indices of obesity, and were significantly correlated with one another, which explained the association of the former with plasma concentrations of high-density lipoprotein (HDL), HDL2, and small, dense low-density lipoproteins. There was no significant relationship between pre-and postheparin lipoprotein lipase activities, but the former were correlated with plasma concentrations of free fatty acids (FFA) and very-lowdensity lipoprotein. Apparently, preheparmn activities of hepatic lipase, but not of lipoprotein lipase, may be a useful measure of the physiological function of "whole body" enzyme activity in cross-sectional and metabolic studies, where heparinization is not possible. Preheparin lipoprotein lipase activities, however, may reflect displacement of the enzyme by FFA and subsequent binding to remnants of triglyceride-rich lipoproteins. 
Materials and Methods

Subjects and samples.
Blood (n = 16 each, P = 0.64).
The amount of sample radioactivity in excess of that of the blank was effectively quadrupled by using 20 L instead of 10 L of plasma in the assay incubations and by taking 2 mL instead of 1 mL of the upper FA fraction for scintillation counting: 45 counts/mm for 20 .tU2 mL vs 10 counts/min for 10 1.dJlO mL (mean of 4 samples each).
Increasing the duration of incubation produced a steady increase in total preheparin lipase activity for the first 1.0 h, followed by a steep but linear increase between 1.0 and 2.0 h, a peak at 2.5 h, and a steep decline to 3.0 h (Fig. 1) . The time chosen for all future incubations was taken from the middle of the linear Time (h) part, i.e., 1.5 h. These manipulations resulted in linear increases in total lipase activity up to a maximum of 22.6 mmol/L FA per hour for pre-and postheparin plasma.
Occasionally, there was poor agreement between assay duplicates, usually with one outlier ("flier") result for which the reported value was on the order of lOOs rather than lOs of units (e.g., duplicate results of 315 and 83 counts/min); this occurred for, e.g., one enzyme in one sample in every 2-3 assays and was overcome by analyzing each sample in triplicate and eliminating the "ifier" results. Incubating postheparin plasma with the antiserum to hepatic lipase resulted in a progressive inhibition of hepatic lipase activity; the inhibition was obvious with 5 L of antiserum and maximal (>93%) with 20 L (Fig. 2) Fig. 4) . Incubation of preheparm plasma with SDS also resulted in a progressive inhibition of hepatic lipase, by --90% at 40 mmol/L (Fig. 4) None of the assay variability appeared due to freeze-thawing:
We saw no significant differences in total preheparin lipase activities in eight samples analyzed fresh (69.8 ± 60 moI/L FA per hour) and after a single freeze-thaw cycle (57.3 ± 46 moI/L per hour; P = 0.33 by one-sample Wilcoxon test).
Pre-and Postheparin Lipases and Plasma Lipids and Lipoproteins
The pre-and postheparin lipase activities and respective correlations are summarized in Table 1 . Both pre-and postheparmn hepatic lipase activities were significantly greater in men than women, the latter being only 66% and 51%, respectively, of the values for the men. There was no significant relationship between pre-and postheparin lipoprotein lipase but there was a strong positive correlation between the two hepatic lipase measurements (Fig. 5) . The correlation was also significant between preheparin lipoprotein and hepatic lipase activities.
The age, body mass index, waist:hip ratio, and lipid and lipoprotein concentrations of the 84 subjects are summarized in Table 2 and correlated with pre-and postheparin enzyme activities. Preheparin lipoprotein lipase was positively correlated with VLDL cholesterol and FFA concentrations (Table 2) ; however, multivariate analysis showed these associations were independent of any relationship between VLDL and FFA (Table 3) . Postheparin lipoprotom lipase activity was negatively correlated with plasma triglycerides and was positively related to age and the plasma concentrations of LDL-I, HDL cholesterol, and HDL2 (Table 2) . The predictorswere includedas covanates in general linear models to establish (a)their relativecontributions to variance in the response vanable, and (b) whetherthey were independently relatedto the response variable. VLDL-C, very-low-density lipoprotein cholesterol. 
